KNBC-TV/Los Angeles Features Personal Lasette by Cell Robotics on Newscast

Business Wire, March 3, 2000

ALBUQUERQUE, N.M.--(BW HealthWire)--March 3, 2000

Cell Robotics International Inc. (OTCBB:CRII):

-- Innovative, FDA-cleared laser designed to make blood sampling easier for 10
million U.S. diabetics and others worldwide

-- KNBC to make the Personal Lasette story available for broadcast to other NBC
stations nationwide

Cell Robotics International Inc. (OTCBB:CRII) today announced that KNBC-TV, the NBC owned and operated Los Angeles TV station, featured its Personal Lasette(R) laser blood-testing product for diabetics on its 4 p.m. newscast on Thursday, March 2.

The story features seven-year old diabetic Kevin Ayers, who mastered the use of the Personal Lasette within a matter of minutes. The boy, who like many people suffering from the disease, must inject insulin two times per day and check his blood sugar level four times per day.

The station, generally considered the leader in news viewership in Southern California, estimates that its 4 p.m. newscast reaches about 495,000 adults daily. The segment on the Personal Lasette will be made available for broadcast to other NBC stations nationwide.

The Personal Lasette is a small laser unit that minimizes pain and reduces soreness associated with monitoring blood sugar levels. Slightly larger than a cell phone, the Personal Lasette pierces the skin with little discomfort, encouraging patients to test their blood much more diligently. Doctors say the punctures heal faster than those inflicted by needle or lancet, the traditional means.

According to the American Diabetes Association, 15.7 million people, or nearly 6 percent of the U.S. population, suffer from the disease. Each day, some 2,200 new cases are diagnosed.

About Cell Robotics International Inc.

Cell Robotics International Inc. (www.cellrobotics.com) is a multi-product medical devices company transitioning from the development phase of a unique and important FDA-approved laser-based device to production and sales in a large and growing market for diabetic patient products and services. The company conducts operations in two product categories: laser-based medical devices and scientific research instruments.